CoChat

Brivaracetam augments short‐term depression and slows vesicle recycling

Yang, Xiaofeng, Bognar, Joseph, He, Tianyu, Mohammed, Mouhari, Niespodziany, Isabelle, Wolff, Christian, Esguerra, Manuel, Rothman, Steven M., Dubinsky, Janet M. · 2015 · Epilepsia
Cited by 47

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Summary: Objective: Brivaracetam (BRV) decreases seizure activity in a number of epilepsy models and binds to the synaptic vesicle glycoprotein 2A (SV 2A) with a higher affinity than the antiepileptic drug levetiracetam (LEV). Experiments were performed to determine if BRV acted similarly to LEV to induce or augment short‐term depression (STD) under high‐frequency neuronal stimulation and slow synaptic vesicle recycling. Methods: Electrophysiologic field excitatory postsynaptic potential (f EPSP) recordings were made from CA 1 synapses in rat hippocampal slices loaded with BRV or LEV during intrinsic activity or with BRV actively loaded during hypertonic stimulation. STD was examined in response to 5 or 40 Hz stimulus trains. Presynaptic release of FM 1‐43 was visualized using two‐photon microscopy to assess drug effects upon synaptic vesicle mobilization. Results: When hippocampal slices were incubated in 0.1–30 μ m BRV or 30 μ m–1 m m LEV for 3 h, the relative CA 1 field EPSP s decreased over the course of a high‐frequency train of stimuli more than for control slices. This STD was frequency‐ and concentration‐dependent, with BRV being 100‐fold more potent than LEV. The extent of STD depended on the length of the incubation time for both drugs. Pretreatment with LEV occluded the effects of BRV. Repeated hypertonic sucrose treatments and train stimulation successfully unloaded BRV from recycling vesicles and reversed BRV s effects on STD, as previously reported for LEV. At their maximal concentrations, BRV slowed FM 1‐43 release to a greater extent than in slices loaded with LEV during prolonged stimulation. Significance: BRV, similar to LEV, entered into recycling synaptic vesicles and produced a frequency‐dependent decrement of synaptic transmission at 100‐fold lower concentrations than LEV. In addition, BRV slowed synaptic vesicle mobilization more effectively than LEV, suggesting that these drugs may modify multiple functions of the synaptic vesicle protein SV 2A to curb synaptic transmission and limit epileptic activity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/epi.13223

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 34

  1. 10.1111/epi.12433 · DOI · Paper page
  2. Kaminski RM, 2012, Targeting SV2A for Discovery of Antiepileptic Drugs. Jasper's Basic Mechanisms of the Epilepsies [Internet]
  3. 10.1016/j.ejphar.2011.04.064 · DOI · Paper page
  4. 10.1124/mol.111.076687 · DOI
  5. 10.1111/cns.12347 · DOI · Paper page
  6. 10.1016/S0896-6273(00)81046-6 · DOI · Paper page
  7. 10.1074/jbc.M800738200 · DOI · Paper page
  8. 10.1016/j.seizure.2009.07.004 · DOI
  9. 10.1111/j.1528-1167.2006.01132.x · DOI · Paper page
  10. 10.1152/jn.00279.2011 · DOI · Paper page
  11. 10.1146/annurev.physiol.64.092501.114547 · DOI · Paper page
  12. 10.1038/2822 · DOI · Paper page
  13. 10.1038/bjp.2008.198 · DOI · Paper page
  14. 10.1074/jbc.C114.584516 · DOI · Paper page
  15. 10.1042/BST0391341 · DOI · Paper page
  16. 10.1038/nmeth.2019 · DOI · Paper page
  17. 10.1109/83.650848 · DOI · Paper page
  18. 10.1016/j.eplepsyres.2015.08.006 · DOI
  19. 10.1113/jphysiol.1967.sp008183 · DOI · Paper page
  20. 10.1002/jcp.20551 · DOI · Paper page
  21. 10.1016/S0896-6273(04)00113-8 · DOI · Paper page
  22. 10.1038/nn.2838 · DOI · Paper page
  23. 10.1126/science.1553547 · DOI · Paper page
  24. 10.1016/S0896-6273(00)00098-2 · DOI · Paper page
  25. 10.1523/JNEUROSCI.4500-05.2006 · DOI
  26. 10.1016/j.neuron.2013.08.010 · DOI
  27. 10.3389/fnsyn.2010.00144 · DOI · Paper page
  28. 10.1074/jbc.271.44.27770 · DOI · Paper page
  29. 10.1523/JNEUROSCI.4051-06.2007 · DOI · Paper page
  30. 10.1523/JNEUROSCI.0924-08.2008 · DOI · Paper page
  31. 10.1074/jbc.M113.512814 · DOI
  32. 10.1111/epi.12930 · DOI · Paper page
  33. 10.1016/0076-6879(91)02027-7 · DOI
  34. 10.1038/nprot.2011.414 · DOI

Cited by

See all 47

Metadata

Authors
Yang, X., Bognar, J., He, T., Mohammed, M., Niespodziany, I., Wolff, C., Esguerra, M., Rothman, S. M., & Dubinsky, J. M.
Venue
Epilepsia
Publisher
Wiley
Published
2015-10-30
Volume
56
Issue
12
Pages
1899-1909
ISSN
  • 0013-9580 (ISSN-L)
  • 1528-1167
OpenAlex
W1943229448
Cited by
47
References
6
FWCI
2.61
Type
journal article
Language
en
Open access
closed
Funders
UCB Pharma

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.